Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency

被引:6
|
作者
Fry, Lewis E. [1 ,2 ,3 ]
Peddle, Caroline F. [1 ,2 ]
Stevanovic, Marta [1 ,2 ]
Barnard, Alun R. [1 ,2 ,3 ]
McClements, Michelle E. [1 ,2 ]
MacLaren, Robert E. [1 ,2 ,3 ]
机构
[1] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford, England
[2] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[3] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England
来源
CRISPR JOURNAL | 2020年 / 3卷 / 04期
关键词
MOUSE MODEL; TRANSCRIPTIONAL INTERFERENCE; THERAPY; MUSCLE; LIVER; EFFICACY; GENOMES; SYSTEM;
D O I
10.1089/crispr.2020.0021
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Adeno-associated virus (AAV) vectors have been widely adopted for delivery of CRISPR-Cas components, especially for therapeutic gene editing. For a single vector system, both the Cas9 and guide RNA (gRNA) are encoded within a single transgene, usually from separate promoters. Careful design of this bi-cistronic construct is required due to the minimal packaging capacity of AAV. We investigated how placement of the U6 promoter expressing the gRNA on the reverse strand to SaCas9 driven by a cytomegalovirus promoter affected gene editing rates compared to placement on the forward strand. We show that orientation in the reverse direction reduces editing rates from an AAV vector due to reduced transcription of both SaCas9 and guide RNA. This effect was observed only following AAV transduction; it was not seen following plasmid transfection. These results have implications for the design of AAV-CRISPR vectors, and suggest that results from optimizing plasmid transgenes may not translate when delivered via AAV.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [1] Systemic Gene Editing for Muscular Dystrophy Using AAV-CRISPR/Cas9
    Bengtsson, Niclas E.
    Hall, John K.
    Chamberlain, Jeffrey S.
    MOLECULAR THERAPY, 2017, 25 (05) : 16 - 16
  • [2] AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
    Li, Ang
    Tanner, Mark R.
    Lee, Ciaran M.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (06) : 1432 - 1441
  • [3] AAV-CRISPR Gene Editing is Negated by Pre-Existing Immunity to Cas9
    Li, Ang
    Lee, Ciaran M.
    Tanner, Mark R.
    Hurley, Ayrea E.
    De Giorgi, Marco
    Jarrett, Kelsey E.
    Davis, Timothy H.
    Doerfler, Alexandria M.
    Bao, Gang
    Beeton, Christine
    Lagor, William R.
    MOLECULAR THERAPY, 2020, 28 (04) : 565 - 566
  • [4] AAV-CRISPR/Cas9 Mediated Gene Editing in Patient RPGR hiPSC-Derived Retinal Organoids
    McDonald, Andrew
    Thanh Nguyen
    Boon, Camiel
    Wijnholds, Jan
    MOLECULAR THERAPY, 2023, 31 (04) : 493 - 494
  • [5] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [6] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [7] Improving Efficiency of an AAV-CRISPR Platform for Lung Gene Editing
    Thomas, Sylvia P.
    Domm, Jakob M.
    Yates, Jacob G. E.
    Pei, Yanlong
    Mehrani, Yegan
    Karimi, Khalil
    Bridle, Byram
    Zhang, Wei
    Thebaud, Bernard
    Wootton, Sarah K.
    MOLECULAR THERAPY, 2022, 30 (04) : 442 - 442
  • [8] AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
    Richards, Daelyn Y.
    Winn, Shelley R.
    Dudley, Sandra
    Nygaard, Sean
    Mighell, Taylor L.
    Grompe, Markus
    Harding, Cary O.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 234 - 245
  • [9] In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia
    Zhao, Huan
    Li, Yan
    He, Lingjuan
    Pu, Wenjuan
    Yu, Wei
    Li, Yi
    Wu, Yan-Ting
    Xu, Chenming
    Wei, Yuda
    Ding, Qiurong
    Song, Bao-Liang
    Huang, Hefeng
    Zhou, Bin
    CIRCULATION, 2020, 141 (01) : 67 - 79
  • [10] Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque
    McCullough, K. Tyler
    Boye, Sanford L.
    Fajardo, Diego
    Calabro, Kaitlyn
    Peterson, James J.
    Strang, Christianne E.
    Chakraborty, Dibyendu
    Gloskowski, Sebastian
    Haskett, Scott
    Samuelsson, Steven
    Jiang, Haiyan
    Witherspoon, C. Douglas
    Gamlin, Paul D.
    Maeder, Morgan L.
    Boye, Shannon E.
    HUMAN GENE THERAPY, 2019, 30 (05) : 571 - 589